RecallGuide.ca
    Health productsUpdated Jan 3, 2026SUBOXONEOfficial source

    SUBOXONE recall in Canada: Overdose or underdose risk

    Share:

    In plain language

    This recall involves SUBOXONE (buprenorphine and naloxone) soluble film and sublingual tablets sold in Canada. It's being recalled because switching between dosage forms or routes of administration could lead to accidental overdose or underdose. Do not change your treatment without first consulting your doctor.

    What to do

    • Do not stop or change your SUBOXONE treatment without talking to your doctor.
    • Consult your doctor if you have any questions or concerns about your medication.
    • Monitor for any signs of overdose or underdose if changes to your medication are made.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    Specific affected products are listed in the official notice.

    Why this matters

    Risk of overdose or underdose

    Do I have this product?

    This recall applies to specific products. Details are listed in the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Risk of overdose or underdose

    What should consumers do?

    Do not stop or change your SUBOXONE treatment without talking to your doctor. Consult your doctor if you have any questions or concerns about your medication. Monitor for any signs of overdose or underdose if changes to your medication are made.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Risk of overdose or underdose

    When was this product recalled?

    This product was recalled on January 7, 2021.

    Is the SUBOXONE brand affected by this recall?

    Yes, SUBOXONE products are affected by this recall. This recall involves SUBOXONE (buprenorphine and naloxone) soluble film and sublingual tablets sold in Canada. It's being recalled because switching between dosage forms or routes of administration could lead to accidental overdose or underdose. Do not change your treatment without first consulting your doctor.